Abstract:BackgroundSepsis is a common disease in intensive care unit in hospital. It is caused by exaggerated host response to infection. Septic myocardial dysfunction plays an important role in pathogenesis of multiple organ failure and subsequent high mortality of patients with sepsis. Our previous studies indicate that activation of NLRP3 inflammasome in cardiac fibroblasts (CF) contributes to sepsis‐induced myocardial dysfunction. The aim of the present study is to identify the role of mitochondrial ROS (mtROS) in the activation of the NLRP3 inflammasome in CF.MethodsCultured CF was primed with LPS (1 ng/mL) followed by ATP (3 mmol/L) treatment for activation of NLRP3 inflammasome. CF mtROS was detected with MitoSOX reagent, a probe specifically detects mitochondrial ROS. NLRP3 inflammasome activation was assessed with Western blot, ELISA and co‐immunoprecipitation.ResultsATP challenge of CF primed with LPS increased CF mtROS production which was attenuated by pretreatment of the LPS primed CF with mito‐TEMPO (25 mmol/L), an ROS scavenger targeted at mtROS. ATP challenge of the LPS primed CF activated the NLRP3 inflammasome as indicated by increase in intracellular levels of NLRP3, pro‐IL‐1β and released IL‐1β. Mito‐TEMPO pretreatment of the CF with LPS+ATP prevented the increase of released IL‐1β in CF. Finally, ATP challenge of the LPS primed CF promoted NLRP3 interaction with the ASC. The Mito‐TEMPO pretreatment of the CF diminished the interaction between the NLRP3 and ASC.ConclusionOur data suggest that mitochondrial derived ROS plays a pivotal role in the activation of the CF NLRP3 inflammasome in sepsis.Support or Funding InformationThe study was supported by Natural Science Foundation of Jiangsu Province (BK20151332) and Natural Science Foundation of China (81370333).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases

Abstract 16702: Mitochondrial Mediated NLRP3 Inflammasome Promotes Cardiomyocyte Death

Nlrp3: A Novel Mediator In Cardiovascular Disease

Role of NLRP3 Inflammasome in Cardiovascular Diseases

NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.

NLRP3 inflammasome: The rising star in cardiovascular diseases

Mitochondrial Contact Sites in Inflammation-Induced Cardiovascular Disease

Unraveling the complex interplay between Mitochondria-Associated Membranes (MAMs) and cardiovascular Inflammation: Molecular mechanisms and therapeutic implications

Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.

Endoplasmic Reticulum Stress and NLRP3 Inflammasome: Crosstalk in Cardiovascular and Metabolic Disorders

Mitochondria-Associated Endoplasmic Reticulum Membranes in Cardiovascular Diseases

Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases

Role and Mechanism of ROS Scavengers in Alleviating NLRP3‐mediated Inflammation

Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic Diseases

Excessive Activation of NMDA Receptors in the Pathogenesis of Multiple Peripheral Organs Via Mitochondrial Dysfunction, Oxidative Stress, and Inflammation

NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases

Reactive Oxygen Species in Cardiovascular Diseases: an Update

Structure and Function of Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases

Reactive oxygen species and NLRP3 inflammasome activation.

Mitochondrial Derived Reactive Oxygen Species Activates NLRP3 Inflammasome in Cardiac Fibroblasts in Sepsis